If you need more lookups,
subscriptions start at $34 USD/month.
David Snead Location
San Diego, CA, US
David Snead Work
Sr. Director, Drug Substance Process Development @ (June 2024 - Present)
Director, Drug Substance Process Development @ (March 2024 - June 2024)
Director, Chemical Development @ (December 2022 - March 2024)
Associate Director, Chemical Development @ (April 2021 - December 2022)
Director of Research @ (May 2018 - April 2021)
Associate Principal Scientist: Process Chemistry @ (May 2017 - May 2018)
Senior Development Chemist: Innovation @ (November 2015 - May 2017)
Development Chemist @ (June 2013 - October 2015)
Post-Doctoral Associate @ (January 2011 - January 2013)
David Snead Education
Massachusetts Institute of Technology
Postdoctoral Associate
2011-2013
University of Florida
Doctor of Philosophy (PhD) (Organic Chemistry)
2005-2010
The University of North Carolina at Chapel Hill
Bachelor of Science (B.S.) (Chemistry)
2001-2005
David Snead Skills
Organic Synthesis
Homogeneous Catalysis
Asymmetric Catalysis
Organic Chemistry
Process Intensification
Renewable Energy
Active Pharmaceutical Ingredients
Chemistry
Catalysis
Pine Chemicals
Flotation
Continuous Flow Synthesis
NMR Spectroscopy
Reagents for Mineral Processing
Nanotechnology
Analytical Chemistry
Mass Spectrometry
Purification
HPLC
Materials Science
Characterization
UV/Vis
Spectroscopy
NMR
David Snead Summary
David Snead, based in San Diego, CA, US, is currently a Sr. Director, Drug Substance Process Development at MapLight Therapeutics, Inc.. David Snead brings experience from previous roles at MapLight Therapeutics, Inc., Mirati Therapeutics and Medicines for All Institute. David Snead holds a 2011 - 2013 Postdoctoral Associate @ Massachusetts Institute of Technology. With a robust skill set that includes Organic Synthesis, Homogeneous Catalysis, Asymmetric Catalysis, Organic Chemistry, Process Intensification and more. David Snead has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different David Snead?
Find contact details for 700 million professionals.